Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

(99m)Tc complexes with activated ester functions; ligands comprising a 3,4-diamino-benzoate backbone.

Osmar Calderon Sanchez1, Ashour Mohammed, Claudia Bauer

  • 1Department of Nuclear Medicine, University of Heidelberg, 69120 Heidelberg, Germany.

Nuclear Medicine and Biology
|April 25, 2006
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New Synthetic Strategies Toward DFO*: Enhanced Yield and Purity of a Key Chelator for <sup>89</sup>Zr Chemistry.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Macropa Scaffold Expansion for Actinium-225 Chelation: A Synthetic Strategy, Labeling Kinetics, and Theoretical Calculations.

Inorganic chemistry·2026
Same author

Comparison of two <sup>18</sup>F-fluorinated glycopeptides for PET imaging of the functional liver mass.

EJNMMI radiopharmacy and chemistry·2026
Same author

Hypothesis-free evaluation of circulating metabolome provides cell-specific insights regarding the role of energy substrate availability in amyotrophic lateral sclerosis.

BMC medicine·2026
Same author

Lipid Regulation of Mechanosensitive Ion Channels.

International journal of molecular sciences·2026
Same author

Collagen Imaging in Human Intracranial Aneurysms - a Translational Proof-of-Concept Study.

Translational stroke research·2026

New ligands facilitate gentle protein labeling with technetium-99m (99mTc) via precomplexation. Researchers synthesized novel heterobifunctional ligands, optimizing 99mTc chelation and protein conjugation for radiopharmaceutical development.

Area of Science:

  • Radiopharmaceutical Chemistry
  • Bioconjugation Chemistry
  • Nuclear Medicine

Background:

  • Preformed technetium-99m (99mTc) chelates with activated esters enable gentle protein labeling through precomplexation.
  • Heterobifunctional ligands are crucial for developing targeted radiopharmaceuticals.

Purpose of the Study:

  • To synthesize and evaluate new heterobifunctional ligands based on 2,3,5,6-tetrafluorophenyl (TFP) 3,4-diaminobenzoates for 99mTc radiolabeling.
  • To compare the 99mTc-complexation and protein-conjugation efficiency of these new ligands with a previously reported ligand (OC2).

Main Methods:

  • Synthesis of novel heterobifunctional ligands (OC1, OC3, OC4) derived from TFP 3,4-diaminobenzoates.
  • Evaluation of 99mTc-complexation yields and kinetics under varying reaction conditions.

Related Experiment Videos

  • Conjugation of 99mTc-labeled ligands to the anti-EGF-receptor monoclonal antibody MAb425 and assessment of labeling efficiency.
  • Main Results:

    • OC1 and OC4 demonstrated effective 99mTc-chelate formation with radiochemical yields of 60% and 70% within 20 minutes, respectively, outperforming OC2.
    • OC3 showed poor complexation (<10%) due to steric hindrance.
    • Protein conjugation yields for 99mTc-OC1 and 99mTc-OC4 were 14% and 7%, respectively, with improved yields at 40°C.
    • The 3,4-phenyl substitution pattern was less suitable for protein conjugation compared to the 4-phenyl position in OC2.

    Conclusions:

    • Novel 3,4-diaminobenzoate-based ligands (OC1, OC4) offer efficient 99mTc complexation for radiopharmaceutical applications.
    • While direct protein conjugation was suboptimal, the 3,4-diaminobenzoate backbone shows promise for designing novel 99mTc N2S2 or N3S complexes.
    • Optimization of reaction conditions (temperature, time) is critical for maximizing radiolabeling efficiency.